BioSpace News Archive

TGaS Advisors named four recipients of the first TGaS Award for the Most Innovative Vendors in Biopharma.

This announcement builds on the success of our previous contract, which proved highly effective in preventing vehicle theft of marked vehicles, and aiding in the recovery and identification of stolen parts.

PTG-300 treatment was well-tolerated, with no serious adverse events or dose-limiting toxicities reported.

If approved, Ampion would be the first intra-articular injection to treat the signs and symptoms of patients with severe osteoarthritis of the knee.

MediaTek Sensio is a powerful advanced health monitoring solution which makes it easy to track heart rate information, blood pressure trends, peripheral oxygen saturation levels and more.

The design of the Phase 3 trial is based on the Phase 2 results that were presented at the 26th Congress of the European Academy of Dermatology and Venereology in September 2017.

The trial will evaluate the combination of ImmunoPulse IL-12 and pembrolizumab in patients with unresectable metastatic melanoma who have progressed or are progressing on an anti-PD-1 therapy.

April Roggasch has been promoted to chief financial officer; Brook Pierce to senior director of creative services and internal marketing; Drake Sauer to art director; Carrie Whiting to human resources director; Steph Todd to director of production and sourcing; Kate Covalt to senior program manager; Tess Dugan and Kacia Hughett to program manager and Dallas Bacon to executive assistant to the chief marketing officer.

The new plates are available immediately.

Incyte Corporation announced today that it will present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 1:30 pm (PST) in San Francisco.